相关实验视频
Updated: Jun 20, 2026

20:16
Detecting Anastasis In Vivo by CaspaseTracker Biosensor
Published on: February 1, 2018
多发性骨髓瘤患者中甲基慢性原发性和二次性固体癌症的影响:从单一中心进行的回顾性研究
Yunfei Ji1,2,3, Hujun Li1,2,3, Huanxin Zhang1,2,3
1Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Frontiers in immunology
|March 25, 2025
概括
甲时原发性原发性恶性固体瘤 (MPMST) 影响多发性骨髓瘤 (MM) 的存活率,特别是在老年男性和晚期ISS阶段的男性中. 肺癌,甲状腺癌和乳腺癌是最常见的二次恶性瘤.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 癌症流行病学 癌症流行病学
背景情况:
- 甲基慢性原发性恶性固体瘤 (MPMST) 对多发性骨髓瘤 (MM) 预后的影响尚未完全理解.
- 在MM之前与MM之后发生的MPMST风险和结果的差异需要澄清.
研究的目的:
- 研究MPMST对MM患者的生存风险和预后的影响.
- 为了比较MPMST在初始MM诊断之前和之后发展的风险.
主要方法:
- 从2015-2023年对2167名MM患者的回顾性分析,确定了34名MPMST.患者.
- 使用千二测试,逻辑回归和Cox模型进行生存分析的统计比较.
主要成果:
- 在MM患者中,MPMST与较短的整体存活率有关 (1.57%的发病率).
- 在男性患者 (HR:3.96),65岁以上患者 (HR:3.30) 和ISS第三阶段患者 (HR:4.08) 中观察到更高的生存风险.
- 卡特-T细胞治疗没有增加第二种癌症发生率,也没有影响整体存活率.
结论:
- 男性性别,65岁以上的年龄和先进的ISS阶段 (III) 与MPMST的MM患者的预后更差.
- 肺癌,甲状腺癌和乳腺癌是最常见的MPMST,在MM诊断之前和之后都发生.
相关概念视频
Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

